DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 16409-34-0, Glycodeoxycholic acid sodium salt, 6w76v75mt1, Glycodeoxycholic acid, sodium salt, Sodium n-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)aminoacetate, Sodium glycyldeoxycholate

Molecular Formula

C₂₆H₄₂NNaO₅

Molecular Weight

471.6 g/mol

InChI Key

VMSNAUAEKXEYGP-YEUHZSMFSA-M

FDA UNII

6W76V75MT1

1 2D Structure

Sodium Glycodeoxycholate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

sodium;2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate

2.1.2 InChI

InChI=1S/C26H43NO5.Na/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3;/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32);/q;+1/p-1/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-;/m1./s1

2.1.3 InChI Key

VMSNAUAEKXEYGP-YEUHZSMFSA-M

2.1.4 Canonical SMILES

CC(CCC(=O)NCC(=O)[O-])C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C.[Na+]

2.1.5 Isomeric SMILES

C[C@H](CCC(=O)NCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+]

2.2 Other Identifiers

2.2.1 UNII

6W76V75MT1

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 16409-34-0

2. Glycodeoxycholic Acid Sodium Salt

3. 6w76v75mt1

4. Glycodeoxycholic Acid, Sodium Salt

5. Sodium N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)aminoacetate

6. Sodium Glycyldeoxycholate

7. Glycodeoxycholate Sodium

8. Glycodeoxycholate (sodium)

9. Unii-6w76v75mt1

10. Einecs 240-455-4

11. Mfcd00036742

12. Glycodeoxycholic Acid Sodium

13. Chebi:87819

14. Ex-a3817

15. Hy-n1427

16. Sodium N-(3,12-dihydroxy-24-oxocholan-24-yl)glycinate

17. Akos024386292

18. As-73534

19. J286.892j

20. Cs-0016856

21. D78059

22. G-5430

23. Q27159959

24. 5beta-cholanic Acid-3alpha,12alpha-diol N-(carboxymethyl)-amide

25. Sodium N-(3alpha,12alpha-dihydroxy-5beta-cholan-24-oyl)glycinate

26. Sodium [(3alpha,12alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]acetate

27. Glycine, N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)-, Monosodium Salt

28. Glycine, N-(3.alpha.,12.alpha.-dihydroxy-5.beta.-cholan-24-oyl)-, Monosodium Salt

29. N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)aminoacetate

30. N-(2-oxo-2-(sodiooxy)ethyl)-3.alpha.,12.alpha.-dihydroxy-5.beta.-cholane-24-amide

31. N-(3.alpha.,12.alpha.-dihydroxy-24-oxo-5.beta.-cholan-24-yl)glycine Sodium Salt

32. (3.alpha.,12.alpha.-dihydroxy-24-oxo-5.beta.-cholan-24-ylamino)acetic Acid Sodium Salt

33. 2-((4r)-4-((1s,2s,11s,16s,5r,7r,10r,14r,15r)-5,16-dihydroxy-2,15-dimethyltetra Cyclo(8.7.0.0(2,7).0(11,15))heptadec-14-yl)pentanoylamino)acetic Acid, Sodium Salt

34. 3.alpha.,12.alpha.-dihydroxy-24-(((sodiooxycarbonyl)methyl)amino)-5.beta.-cholan-24-one

35. Glycine, N-((3.alpha.,5.beta.,12.alpha.)-3,12-dihydroxy-24-oxocholan-24-yl)-, Monosodium Salt

36. Glycine, N-((3.alpha.,5.beta.,12.alpha.)-3,12-dihydroxy-24-oxocholan-24-yl)-, Sodium Salt (1:1)

37. Glycine, N-[(3??,5??,12??)-3,12-dihydroxy-24-oxocholan-24-yl]-, Sodium Salt (1:1)

38. Sodium (((3.alpha.,5.beta.,12.alpha.,20r)-3,12-dihydroxy-24-oxocholan-24-yl)amino)acetate

39. Sodium 2-(((4r)-4-((3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta(a)phenanthren-17-yl)pentanoyl)amino)acetate

40. Sodium 2-[(4r)-4-[(1r,3as,3br,5ar,7r,9as,9bs,11s,11ar)-7,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanamido]acetate

41. Sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate

2.4 Create Date

2008-02-05

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₄₂NNaO₅
Molecular Weight	471.6 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	6
Exact Mass	471.29606772 g/mol
Monoisotopic Mass	471.29606772 g/mol
Topological Polar Surface Area	110 Å²
Heavy Atom Count	33
Formal Charge	0
Complexity	734
Isotope Atom Count	0
Defined Atom Stereocenter Count	10
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

ABOUT THIS PAGE

Find Sodium Glycodeoxycholate manufacturers, exporters & distributors on PharmaCompass

Sodium Glycodeoxycholate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?